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Abstract:  In a prospective descriptive laboratory study, 25 Helping Hand
™ (HH)   
(10 without and 15 with reminder system) and 50 Medication Event Monitoring Systems 
(MEMS) (25 with 18-month and 25 with 2-year battery life) were manipulated twice daily 
following a predefined protocol during 3 consecutive weeks. Accuracy was determined 
using the fixed manipulation scheme as the reference. Perfect functioning (i.e., total 
absence of missing registrations and/or overregistrations) was observed in 70% of the HH 
without, 87% of the HH with reminder, 20% MEMS with 18 months, and 100%   
with 2-year battery life respectively. 
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1. Background 
 
Non-adherence is a prevalent problem in chronically ill populations and it may result in poor 
clinical and economic outcomes [1]. Measurement of medication non-adherence is crucial to identify 
patients at risk for poor outcomes and to evaluate adherence-enhancing interventions. Several 
assessment methods exist, but all have inherent weaknesses [2]. Electronic monitoring (EM) is often 
promoted as “the gold standard”, as it is the only assessment tool allowing continuous monitoring over 
time, generating information regarding taking and timing of drug intake. It is also capable of capturing 
minimal deviations from the prescribed regimen, which is an asset particularly for populations   
(e.g., transplant or HIV) in which minimal deviations from dosing schedule are already sufficient to 
result in poor clinical outcomes [3,4].  
To date, the Medication Event Monitoring System (MEMS, Aardex, CH) has been most frequently 
used. It consists of a pill bottle, fitted with a cap, containing a microelectronic circuit, that registers the 
date and time of opening of the bottle (see Figure 1). Yet, the MEMS system has important drawbacks: 
it may lead to practical (e.g., the pill bottle is rather large) or confidentiality issues (e.g., HIV patients 
have addressed privacy issues) [4]. Besides, based on the safety regulations from the pharmaceutical 
companies, some medication tablets (e.g., immunosuppressants) need to stay in the blister until actual 
ingestion to avoid changes in stability of the drugs due to exposure to moisture, air, light, and 
microbiological cross-contamination [5]. In order to fit in the EM medication container, the blister 
needs to be cut in individual packaged pills.  
Figure 1. The Medication Electronic Monitoring System (MEMS) (Aardex, Switzerland). 
 
Figure 2. The Helping Hand
TM (HH) (Bang & Olufsen Medicom, Denmark). 
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In recent years, other electronic monitoring devices have been developed. Bang & Olufsen, 
Medicom (Denmark) developed the Helping Hand
™ Data Capturing (HH), an electronic monitoring 
tool with similar functions compared to the MEMS, but suitable for blister packages. This new device 
seems very promising to cover e.g., privacy problems because it is smaller and easy to hide compared 
to e.g., MEMS. Furthermore, the blister does not need to be cut anymore to fit into the device. Besides, 
the reminder system consists of Light Emitting Diodes (LED) reminders providing feedback to the 
user regarding their medication behavior within the previous week via a patented traffic-light   
color-codes system. A red flashing lamp indicates major NA (“alarm”), orange indicates minor NA 
(“you missed doses”) and green means perfect adherence (“everything is fine”). The acoustic function 
yields a beeping signal at the time of the scheduled medication intake.  
Most of EM devices are used in patient populations without prior formal testing by an independent 
researcher to determine if the devices function correctly, and whether the data stored in the device 
reflect the actual behavior performed by the patient [6]. The accuracy of all electronic monitoring 
devices should be tested before they can be implemented in clinical studies or daily clinical practice. 
Elements that can be considered in the testing can be derived from a recently developed conceptual 
framework [6]. Accuracy is the degree of veracity or conformity of a measured quantity to its true 
value. The accuracy of a measurement process is usually tested in a semi-laboratory setting, in which 
the devices under study are manipulated by a researcher following a predefined, standardized protocol. 
The latter is used as the reference standard against which deviations in terms of underregistration or 
overregistration of a given behavior are compared. No studies have been published so far, testing the 
accuracy of electronic monitoring devices. The primary aim of this study was to test the accuracy of 
the Helping Hand
™ and the MEMS.  
 
2. Methodology 
 
2.1. Design 
 
The accuracy of a measurement process is usually established by repeatedly measuring a traceable 
reference standard. This can best be done in a situation in which several devices are manipulated in 
standardized circumstances following a predefined schedule that is considered to be the gold standard. 
Therefore, to test the accuracy of the HH and the MEMS, a prospective sequential descriptive 
laboratory study was executed. 
 
2.2. Sample and Setting 
 
In total, we tested 25 HH devices and 50 MEMS devices. 
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2.2.1. Helping Hand
™ 
 
The devices tested in this study were intended to be used in an adherence intervention study. 
Twenty-five HH
 devices were randomly selected from a batch of 831 devices by an independent 
researcher using a random numbers table: 10 HH
  monitoring systems (randomly selected   
from 406 systems with monitoring function only—i.e., 2.5% of the devices with monitoring function 
only) and 15 HH
 devices (randomly selected from the 425 devices that not only have the electronic 
monitoring function, but also an acoustic reminder and visual feedback function—i.e., 3.5% of   
the devices).  
 
2.2.2. Medication Event Monitoring System  
 
For the MEMS devices, two sets with a different battery life were selected. A first set consisted  
of 25 devices that had a battery life of 18 months and had been already activated at the time of delivery 
to our research unit. A second set of 25 MEMS devices had a battery life of 2 years, but needed to be 
activated by the researchers. These were randomly selected from 50 devices purchased for use in a 
clinical study. Both types were MEMS 6 Smart Caps. The purpose of the present study was not 
revealed to the manufacturers. 
 
2.3. Variables and Measurement 
 
A three week manipulation schedule was developed as a reference. This is considered to be the 
‘gold standard’. In order to mimic the twice daily regimen of medication taking, every device was 
manipulated twice daily with exactly twelve hours between two manipulations. To imitate patients that 
take extra medications or take their medication on variable hours, on three randomly chosen days  
(day 9, 12 and 18) there were four manipulations (every 6 hours) in each day. The researcher noted the 
following information for the Helping Hand
™ testing on a standardized sheet: date; exact time of 
manipulation of the system (i.e., removal of the blister); color of the visual feedback lamp at the time 
of the scheduled manipulation (in the devices with this function only); and time that the reminder 
function started beeping (in the devices with this function only). With respect to the MEMS, the 
following information was noted: date; and exact time of manipulation of the system (i.e., removal of 
the cap). 
 
2.4. Procedure 
 
After having randomly selected the devices, each of the HH
 monitoring systems were labeled with a 
number (1–15 for the electronic monitoring devices with reminder and feedback function, and 16–25 
for the devices with monitoring only). At the time stated in the manipulation protocol, all devices were 
manipulated. More specifically, for the HH devices, a manipulation was defined as “removing the 
blister out of the device, waiting until you can hear a beeping signal and after the signal reinserting the Sensors 2010, 10                  
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blister into the device”. The devices were manipulated as if there was a twice daily medication regimen 
with an intake at 8.30 o’clock in the morning and 8.30 o’clock in the evening. All the devices were 
always manipulated in the same order, starting with device 1, afterwards device 2, etc. with 30-second 
intervals between 2 consecutive devices. The exact date and time of the manipulation were always 
registered using the same watch, which was synchronized online with the atom clock. After each 
manipulation, the date and time were noted on a special sheet developed for the purpose of this study. 
With respect to the HH devices with an acoustic reminder, the starting time of the beeping signal was 
also registered. For the MEMS devices the same procedure was used. A manipulation was defined as: 
removing the cap of the bottle, waiting for 3 seconds, and closing the bottle with the cap. Quality 
control was performed by a second researcher by unannounced observation at randomly selected time 
points spread over the 3-week time period.  
 
2.5. Statistical Analysis 
 
After the 3-week data collection period, the stored data were downloaded on a computer. For the 
HH devices, the HelpView software was used. For the MEMS devices, the powerview program was 
used. For data analysis, Office XP Excel was used. The date and time stamps indicated on the printouts 
of the HH and MEMS were compared with the date and times indicated on the manipulation scheme 
from the researcher (i.e., the reference value). Data analysis was performed at 2 levels, i.e., “event 
level” (based on the number of manipulations) and “device level”. On the manipulation event level, the 
following calculations were made: (1) for HH without reminder system: % missing and 
overregistrations of devices per total number of events (420 = 10 devices × 42 manipulations), (2) for 
the HH with reminder system: % missing and overregistrations of devices per total number of events 
(630 = 15 devices × 42 manipulations), (3) for MEMS with 18-month battery life: % missing and 
overregistrations per total number of events (1,050 = 25 devices × 42 manipulations) and (4) for 
MEMS with 2-year battery life: % missing and overregistrations per total number of events   
(1,050 = 25 devices × 42 manipulations). 
On the Electronic Monitoring device level, we calculated: (1) the % missing and overregistrations 
of HH (N = 25 = 10 basic devices and 15 reminder devices) and MEMS devices (N = 50 = 25 devices  
with 18-month battery life and 25 devices with 2-year battery life); and (2) number of devices   
with 100% correct registrations (total number of devices = 75).  
The MEMS is programmed to ignore extra registrations within 15 minutes after the initial 
registration. In order to enhance the comparability of the results of the MEMS and HH, we also deleted 
extra registrations in the HH that happened within 15 minutes after the initial registration. Hence, these 
registrations were not categorized as an overregistration. 
 
3. Results 
 
In total, 3,150 manipulations were conducted. In Table 1, the results of the accuracy of the Helping 
Hand™ and the MEMS devices are described. At ‘event level’, there were 5/420 (1.20%)   Sensors 2010, 10                  
 
 
1657
1657
and 1/630 (0.16%) missing registrations for the HH devices without reminder and HH devices with 
reminder, respectively. For the MEMS devices, there were 33/1050 (3.14%) for MEMS with 18-month 
battery life, but no missing registrations for MEMS with 2-year battery. Only a few overregistrations 
were recorded: 2/420 (0.48%) in the HH without reminder and 1/630 (0.16%) in the HH with 
reminder. There were no overregistrations in either MEMS group. 
Table 1. Results of the accuracy of the Helping Hand™ and the MEMS. 
 
HH without 
reminder 
HH with 
reminder 
MEMS 
18 month 
battery 
MEMS 
2 year battery 
Event level 
Missing registrations  5/420 (1.20%)  1/630 (0.16%)  33/1050 (3.14%)  0/1050 (0%) 
Overregistrations  2/420 (0.48%)  1/630 (0.16%)  0/1050 (0%)  0/1050 (0%) 
Device level 
Missing registrations  3/10 (30%)  1/15 (6.67%)  5/25 (20%)   0/25 (0%) 
Overregistrations  2/10 (20%)  1/15 (6.67%)  0/25 (0%)  0/25 (0%) 
100% correct functioning 7/10 (70%)  13/15 (87%)  20/25 (80%)  25/25 (100%) 
 
At ‘device level’, HH devices without reminder (N = 10) performed worse compared to HH with 
reminder (N = 15). Three (30%) HH without reminder had missing values in comparison   
with 1/15 (6.67%) of the HH with reminder. The number of missing registrations of a device ranged 
between 1 and 2. The MEMS with short battery life performed worse compared to the MEMS devices  
with 2-year battery life. Twenty (80%) MEMS with short battery life had missing values in 
comparison to 0.0% in the other MEMS system. Overregistrations were recorded in 2/10 (20%) of HH 
without reminder and in 1/15 (6.67%) of HH with reminder. No overregistrations were recorded with 
the MEMS systems. Overall, 7 out of 10 (70%) HH devices without reminder functioned perfectly. For 
the HH devices with reminder system this was 13/15 (87%). For the MEMS devices, five (20.00%) of 
the devices with 18-month battery functioned perfectly. For the MEMS devices with 2-year battery life 
this was 100.0%. 
 
4. Discussion and Conclusion 
 
To our knowledge, this was the first independent study assessing the accuracy of MEMS and HH 
devices using data of a fixed manipulation scheme as reference standard. Actually, both systems show 
some measurement error ranging between 0.16% and 1.20% at the event level for the HH and   
between 0% and 3.14% for the MEMS. At the device level, 70%–87% of HH functioned 100% 
correctly. This ranged between 20%–100% for the MEMS. The results suggest that battery life plays 
an important role in the accuracy of the MEMS: more specifically, a battery life of 2 years increases 
the likelihood of 100% correct functioning. For the HH, under- and overregistrations occur. The results 
of this study confirm Denhaerynck’s [6] advice to test the performance of electronic monitoring 
technology before use in clinical studies is imperative.  Sensors 2010, 10                  
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The reasons for under- and over-registrations remain unclear. For the MEMS, we used the same 
types of caps, i.e., 6 SMART CAP. We also ordered the devices with shorter battery life in November; 
hence weather conditions during transportation could have played a role. Both Aardex and Bang & 
Olufsen Medicom already performed extensive tests on their products. More specifically, Aardex 
performed tests on the water-resistance, temperature resistance (from 0 °C to 60 °C), shock resistance, 
child resistance, battery life, and long term (1 year) daily use of the MEMS, to ensure correct recording 
of openings and closings of the MEMS monitor. Aardex reports a failure rate below 0.5% [7]. The 
MEMS are CE-marked and have successfully passed the Electromagnetic Compatibility Tests run by 
Montena, a test laboratory accredited by Metas, the Swiss Federal Office of Metrology and 
Accreditation. Bang & Olufsen, Medicom also tested the quality of the devices in a stable laboratory 
situation where they are exposed to extreme circumstances such as heat, water and shocks. Given that 
both manufacturers expose their devices to extreme temperatures, decreases the likelihood that weather 
conditions during transportation have played a role. Our study focused more on the accuracy of the 
devices when manipulated in order to mimic a patient’s medication intake in stable circumstances, i.e., 
without external influences such as heat, water, shocks, specific patient characteristics such as tremor, 
or forgetfulness. Given that we observed measurement errors, albeit infrequently, and irrespective of 
the reason for this, it is recommended that all electronic devices undergo accuracy testing before using 
them in clinical studies or daily life.  
Researchers and clinicians who use either the HH or MEMS should be aware of the possibility of 
measurement errors. Indeed, an inadequate measurement of non-adherence due to inaccurate EM 
devices can have clinical consequences, particularly in diseases in which minor deviations from 
prescribed dosing and timing of drug administration are enough to increase the risk of poor clinical 
outcomes [3,8]. In transplantation, for instance, taking less than 98% of the immunosuppressive doses 
results in significantly more graft losses [9]. Similarly, in HIV, taking less than 95% of the 
antiretroviral drugs could be harmful in terms of suboptimal viral suppression and development of 
resistance [4]. If a patient is wrongfully labeled as adherent because of overregistration, a clinician 
may think a patient experiences no effect of a given treatment, and may subsequently change the dose 
or the type of medication. On the other hand, if there are underregistrations, patients will be wrongly 
categorized as non-adherent, yielding patients to be blamed for their presumed non-adherence, whereas 
patients themselves become confused about their actual medication behavior. Therefore, very sensitive 
measurement tools that function 100% correctly are needed to capture minor deviations in   
medication intake. 
 
5. Methodological Issues 
 
Although this is an important study to identify the accuracy of the MEMS and the Helping Hand™ 
devices, there are some methodological issues that we need to address. First, since the study protocol is 
performed by a single researcher, it is important that the correctness of carrying out the protocol is 
checked by an additional independent researcher. In the present study, a second researcher, who was 
familiar with the manipulation protocol, performed a quality control by observing the researcher at Sensors 2010, 10                  
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randomly selected time points spread over the 3-week time period. In addition, this independent 
researcher replicated the study in exactly the same manner. The results obtained by this second 
researcher (results not reported) were comparable to those reported in this article, indicating that there 
is no influence from the researcher who executed the study. In addition, during the analysis, all data 
were also checked by this second researcher, to minimize error while importing the data from the 
reference standard and the registered manipulations to the computer. She also particularly checked if 
the bottles remained open long enough before closing them (i.e., at least 3 seconds according to the 
manufacturer), or whether the blister was removed from the HH long enough to enable a registration. 
Hence speed of manipulation of the devices did not play a role in the results.  
Second, we used a three weeks testing period. This could be considered as relatively short. We 
decided to monitor during three weeks because of practical reasons (day and night observations). 
Indeed, executing such a laboratory study and analyzing the data are very time consuming. Studies 
including a longer testing period are advocated to get an overview of the influence of time on the 
accuracy of the EM device.  
Third, a limited number of devices were tested. We tried to avoid possible bias by randomly 
selecting the devices from the available batches. In the future, accuracy studies could be replicated 
using a larger number of the different MEMS and Helping Hand™ devices.  
Fourth, we tested MEMS and HH in stable laboratory circumstances. However, it is important that 
the accuracy of EM devices is also tested when used in daily life. For example, carrying the Helping 
Hand™ in a purse may evoke a medication intake registration, recorded by movements during walking 
and not by a medication intake registration event.  
Fifth, accuracy is only one crucial aspect of electronic monitoring. In addition to the objective tests, 
further research specifically focusing on the subjective dimension, i.e., the patients’ perspective, is 
important. As patients are the end users, EM devices have to be evaluated with respect to user 
performance, satisfaction and acceptability. Therefore, we also conducted a study to evaluate the user 
experiences with respect to the HH. The results of this study will be reported separately. 
 
6. Conclusions 
 
This was the first independent study assessing reliability of MEMS and HH using data of a fixed 
manipulation scheme as reference standard. We observed missing registrations in 1.20% and 0.16% of 
HH without and with reminder, respectively; and in 3.14% and 0% of MEMS with 18 months and  
with 2-year battery life, respectively. Overregistrations were recorded in 0.48% of HH without 
reminder and in 0.16% of HH with reminder. No overregistrations occurred in MEMS. Perfect 
functioning was observed in 70% of the HH without, 87% of the HH with reminder, 20% MEMS  
with 18 months, and 100% with 2-year battery life respectively. We recommend that the accuracy of 
all EM systems is formally tested before using them in research or clinical settings.  
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